Woo Hyun Paik
Welcome,         Profile    Billing    Logout  
 7 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Park, Do Hyun
DHP_ALPS, NCT05832047: Aggressive Hydration With Lactated Ringer's Solution Versus Plasma Solution for the Prevention of Post ERCP Pancreatitis

Active, not recruiting
4
844
RoW
Plasma solution (4-hour aggressive hydration), Plasma solution-A Inj., Lactated Ringer solution (4-hour aggressive hydration), Hartmann Solution inno.N, 8-hour aggressive hydration, 8-h AH
Do Hyun Park, HK inno.N Corporation
Pancreatic Disease
07/24
01/25
NCT05299099: Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301

Completed
3
60
RoW
IN-C006 inj., IN-C006 inj, RCN301
HK inno.N Corporation
Parenteral Nutrition
12/22
12/22
NCT05337228: Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

Completed
3
59
RoW
IN-C006 Peri inj., RPN301
HK inno.N Corporation
Parenteral Nutrition
02/23
02/23
IPLUS, NCT03618758: Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

Completed
1/2
35
RoW
Paclitaxel, (Genexol®), mFOLFOX6 regimen
Seoul National University Bundang Hospital, Boryung Pharmaceutical Co., Ltd, B. Braun Korea Co., Ltd.
Gastric Cancer Stage IV, Peritoneal Carcinomatosis, Intraperitoneal Paclitaxel, mFOLFOX6
08/23
12/23

Download Options